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	 Five	new	thiosemicarbazone	compounds	derived	from	N(4)‐methylthiosemicarbazide	and	5‐
bromo‐2‐hydroxybenzaldehyde	 (1),	 2,4‐dihydroxybenzaldehyde	 (2),	 3‐ethoxy‐2‐hydroxy
benzaldehyde	 (3),	 3‐tert‐butyl‐2‐hydroxybenzaldehyde	 (4),	 and	 2‐acetylpyridine	 (5)	 have
been	synthesized.	The	molecular	structures	of	the	prepared	compounds	were	identified	using
by	 single	 crystal	 X‐ray	 crystallography.	 The	 binding	 properties	 of	 the	 compounds	with	 calf
thymus	 DNA	were	 analyzed	 by	UV,	 fluorescence	 titration,	 and	 viscosity	measurements.	 The
cytotoxic	properties	of	 the	compounds	were	tested	against	human	colorectal	cell	 lines	 (HCT
116).	The	compounds	showed	greater	pronounced	activity	than	the	standard	reference	drug
5‐fluorouracil	 (IC50	 =	 7.3	 μM).	 The	 results	 showed	 that	 the	 activity	 strength	 of	 these
compounds	 depends	 on	 the	 lipophilic	 properties	 that	 provided	 by	 the	 terminal	 N(4)‐
substituent	 and	 aromatic	 ring‐substituent,	 as	 well	 as	 the	 planarity	 that	 provided	 by	 the
geometrical	and	conformational	structures	of	the	compounds.	
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1.	Introduction	
	
The	discovery	of	the	antiviral,	antibacterial	and	antitumor	
activities	 of	 the	 thiosemicarbazone	 ligands	 has	 stimulated	
numerous	investigation	concerning	synthesis,	characterization	
and	biological	 relevance	 of	 such	 compounds	 [1‐6].	 Thiosemi‐
carbazones	 belong	 to	 a	 large	 group	 of	 thiourea	 derivatives,	
whose	biological	activities	are	a	function	of	parent	aldehyde	or	
ketone	 moiety	 [7,8].	 Conjugated	 N‐N‐S	 tridentate	 ligand	
system	 of	 thiosemicarbazide	 seems	 essential	 for	 anticancer	
activity,	possibly	due	to	the	observation	that	structural	altera‐
tions	that	hinder	a	thiosemicarbazone’s	ability	to	function	as	a	
chelating	agent	tend	to	destroy	or	reduce	its	medicinal	activity	
[9].	 Furthermore,	 structural	 studies	 have	 shown	 that	
thiosemicarbazone	 derivatives	 containing	 phenolic	 oxygen	
have	 very	 interesting	 complexing	 properties,	 acting	 as	
tridentate	 O‐N‐S	 donor	 ligands	 [10‐15].	 The	 molecular	
interaction	 of	 compounds	 and	 DNA	 has	 received	 increasing	
interest	 in	 recent	 years	 because	 of	 its	 importance	 in	 design	
and	development	of	 chemotherapeutic	drugs,	 this	 interaction	
is	 important	 for	 understanding	 the	 molecular	 mechanism	 of	
drug	action	for	designing	a	specific	DNA	targeted	drug	[16‐20].	
From	 the	 other	 hand,	 the	 antiproliferative	 activity	 of	
compounds	 also	 has	 received	 more	 attention	 because	 such	
compounds	 can	 be	 used	 as	 agents	 in	 biotechnology	 for	
development	a	new	drugs	[21‐23].	Recent	studies	showed	that	
the	substitution	on	the	terminal	N(4)	of	thiosemicarbazone	is	
much	 improved	 their	 biological	 activities	 [24‐27].	 We	 here	
report	 the	 synthesis,	 characterization,	 structural	 elucidation,	
DNA	 binding	 and	 antiproliferative	 activity	 for	 novel	
derivatives	 of	 N‐(4)‐methylthiosemicarbazones	 shown	 in	
Scheme	1.	
	
 
 
Scheme	1	
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2.	Experimental	
	
2.1.	Materials	and	instrumentation	
	
Melting	 points	 were	 measured	 using	 a	 Stuart	 Scientific	
SMP1	melting	point	apparatus.	The	infrared	(IR)	spectra	were	
recorded	on	 a	Perkin	Elmer	 system	2000	 spectrophotometer	
using	the	KBr	disc	method.	The	1H	and	13C	NMR	spectra	were	
recorded	on	a	Bruker	500	MHz,	using	tetramethylsilane	as	an	
internal	 standard	 and	 DMSO‐d6	 as	 the	 solvent.	 Elemental	
analysis	was	carried	out	using	a	Perkin	Elmer	2400	series‐11	
CHN	 analyzer.	 The	 electronic	 and	 fluorescent	 spectra	 were	
recorded	 on	 a	 Perkin	 Elmer	 Lambda‐35	 spectrophotometer	
and	 a	 Jasco	 FP‐750	 spectrophotometer,	 respectively.	 X‐ray	
crystallographic	data	were	recorded	on	a	Bruker	SMART	CCD	
diffractometer	using	graphite	monochromated	MoKα	radiation	
(λ	 =	 0.71073	 Å)	 at	 100	 K.	 The	 data	 collected	 were	 reduced	
using	 SAINT	 program.	 The	 structure	 of	 all	 compounds	 was	
solved	 using	 the	 SHELXL‐97	 software	 package,	 and	 the	
molecular	graphics	were	created	using	SHELXTL	[28].	All	non‐
hydrogen	 atoms	 were	 anisotropically	 refined.	 All	 of	 the	
chemicals,	 including	 thiosemicarbazide,	 aldehydes,	 and	 the	
solvents	were	purchased	from	Sigma‐Aldrich.	
	
2.2.	DNA	binding	assay	
	
The	binding	of	compounds	with	calf	thymus	DNA	(CT‐DNA)	
were	 investigated	 in	 6.3	 mM	 Tris‐HCl/50	mM	 NaCl	 buffer	
(pH	=	7).	The	DNA	stock	solution	was	prepared	by	dissolving	a	
suitable	 amount	 of	 DNA	 in	 6.3	 mM	 Tris‐HCl/50	 mM	 NaCl	
buffer	(pH	=	7)	at	room	temperature	and	stored	in	refrigerator	
for	2	days.	A	 solution	of	CT‐DNA	 in	 the	buffer	provided	a	UV	
absorbance	 ratio	 at	 260	and	 280	 nm	 of	 ca.	 1.9:1,	 which	
indicates	 that	 the	 DNA	 was	 sufficiently	 free	 of	 protein.	 The	
DNA	 concentration	 was	 estimated	 by	 the	 UV	 absorbance	 at	
260	 nm	 using	 the	 known	 molar	 absorption	 coefficient	 of	
6600	M‐1·cm‐1	 [29].	 The	 UV‐Vis	 spectra	 were	 scanned	 at	
wavelengths	 ranging	 from	230	to	 600	nm	using	 the	Tris/HCl	
buffer	solution	as	 the	 reference.	Fluorescence	emission	assay	
was	 carried	 out	 using	 the	 aforementioned	 method.	
Fluorescence	 spectra	 were	 scanned	 at	 wavelengths	 ranging	
from	200	to	800	nm	using	the	Tris/HCl	buffer	solution	as	the	
reference.	 Viscosity	 was	 measured	 using	 a	 Cannon	 Manning	
Semi‐Micro	viscometer	immersed	in	a	thermostatic	water	bath	
at	 37	 °C.	 Flow	 times	were	measured	manually	with	 a	 digital	
stopwatch.	Viscosity	values	were	calculated	from	the	observed	
flow	 time	 of	 DNA‐containing	 solutions	 (t)	 corrected	 by	
observed	 flow	 time	 of	 solvent	 mixture	 used	 (t0),	 ɳ	 =	 t	 ‐	 t0.	
Viscosity	data	are	presented	as	(ɳ/ɳ0)1/3	versus	the	ratio	of	the	
concentration	(r)	of	the	ligand‐DNA	solutions,	where	ɳ	and	ɳ0	
are	 the	 viscosity	 of	 the	 ligand	 in	 presence	 of	 DNA	 and	 the	
viscosity	of	DNA	alone,	respectively	[30].	
	
2.3.	Antiproliferation	assay	
	
2.3.1.	Preparation	of	cell	culture		
	
Human	 colorectal	 cancer	 cells	 (HCT	 116)	 were	 grown	
under	optimal	incubator	conditions.	Cells	that	have	reached	a	
confluency	 of	 70‐80%	were	 chosen	 for	 cell	 plating	 purposes.	
Old	 medium	 was	 replaced	 by	 aspiration.	 After	 that	 the	 cells	
were	washed	with	sterile	phosphate	buffered	saline	(PBS)	(pH	
=	 7.4),	 2‐3	 times,	 the	 intact	 layer	 of	 attached	 cells	 was	
subjected	 to	 trypsinization.	 Cells	 were	 incubated	 at	 37	 °C	 in	
5%	CO2	for	3‐5	min.	Then,	the	flasks	containing	the	cells	were	
gently	 tapped	 to	 aid	 cells	 segregation	 and	 observed	 under	
inverted	microscope	(to	confirm	the	segregation	of	the	cells	is	
completed).	Trypsin	activity	was	 inhibited	by	adding	5	mL	of	
fresh	 complete	media	 supplied	with	 10%	 fetal	 bovine	 serum	
(FBS).	 Cells	 were	 counted	 and	 diluted	 to	 get	 a	 final	
concentration	 of	 2.5×105	 cells/mL,	 and	 inoculated	 into	wells	
(100	 µL/well).	 Finally,	 plates	 containing	 the	 cells	 were	
incubated	at	37	°C	with	an	internal	atmosphere	of	5%	CO2.		
	
2.3.2.	MTT	assay	
	 	
Cytotoxicity	 of	 the	 compounds	was	 evaluated	 using	MTT	
assay	 against	 HCT	 116	 cells	 [31].	 HCT	 116	 cells	 (1.5×105	
cells/mL,	 100	 µL/well)	 were	 seeded	 in	 96‐wells	 microtitre	
plate.	 Then	 the	 plate	 is	 incubated	 in	 CO2	 incubator	 for	
overnight	 in	order	to	allow	the	cell	 for	attachment.	100	µL	of	
test	substance	were	added	into	each	well	containing	the	cells.	
Test	 substance	 was	 diluted	 with	 media	 into	 the	 desired	
concentrations	 from	 the	 stock.	 The	 plates	were	 incubated	 at	
37	 °C	with	an	 internal	 atmosphere	of	5%	CO2	 for	 72	h.	After	
this	 treatment	period,	 20	 µL	 of	MTT	 reagent	was	 added	 into	
each	 well	 and	 incubated	 again	 for	 4	 h.	 After	 this	 incubation	
period,	50	µL	of	MTT	lysis	solution	(DMSO)	was	added	into	the	
wells.	 The	 plates	 were	 further	 incubated	 for	 5	 min	 in	 CO2	
incubator.	 Finally,	 plates	 were	 read	 at	 570	 and	 620	 nm	
wavelengths	 using	 a	 standard	 ELISA	microplate	 reader.	 Data	
were	recorded	and	analyzed	for	the	assessment	of	the	effects	
of	 test	 substance	 on	 cell	 viability.	 The	 percentage	 of	 growth	
inhibition	 was	 calculated	 from	 the	 optical	 density	 (OD)	 that	
was	 obtained	 from	 MTT	 assay,	 i.e.,	 hundredth	 multiple	 of	
subtracted	OD	value	of	 control	 and	survived	cells	over	OD	of	
control	cells.	
	
2.4.	Synthesis	
	
2.4.1.	Synthesis	of	(E)‐2‐(5‐bromo‐2‐hydroxybenzylidene)‐
N‐methylhydrazinecarbothioamide	(1)	
	
A	 solution	 of	 5‐bromo‐2‐hydroxybenzaldehyde	 (0.95	 g,	
4.75	mmol)	 in	ethanol	(20	mL)	was	added	to	a	solution	of	4‐
methyl‐3‐thiosemicarbazide	(0.5	g,	4.75	mmol)	in	ethanol	(20	
mL).	The	 resulting	yellow	solution	was	 refluxed	with	stirring	
for	2	h	and	then	filtered.	The	filtrate	was	left	to	stand	at	room	
temperature	 for	 two	 days,	 and	 plate	 yellow	 crystals	 were	
obtained.	M.p:	 185‐187	 °C.	 Yield:	 1.06	 g,	 78%.	 FT‐IR	 (KBr,	 ν,	
cm−1):	3398	 (s,	NH),	3125	 (m,	OH),	1600	 (m,	C=N),	1553	 (m,	
CaroO),	 1271	 (m,	 C=S).	 1H	NMR	 (500	MHz,	DMSO‐d6,	 δ,	 ppm):	
3.01	(s,	3H,	CH3),	6.83‐8.15	(m,	3H,	Ar‐H),	8.28	(q,	1H,	CS‐NH),	
8.57	 (s,	 1H,	 CH=N),	 11.42	 (s,	 1H,	N‐NH).	 13C	 NMR	 (125	MHz,	
DMSO‐d6,	 ppm):	 30.80	 (CH3),	 111.04‐137.01	 (C‐Ar),	 155.44	
(C=N),	177.48	(C=S).	Anal.	calcd.	for	C9H10BrN3OS:	C,	37.51;	H,	
3.50;	N,	14.58.	Found:	C,	37.49;	H,	3.45;	N,	14.55%.		
	
2.4.2.	Synthesis	of	(E)‐2‐(2,4‐dihydroxybenzylidene)‐N‐
methylhydrazinecarbothioamide	(2)		
	
A	 solution	 of	 2,4‐dihydroxybenzaldehyde	 (0.65	 g,	 4.75	
mmol)	in	ethanol	(20	mL)	was	added	to	a	solution	of	4‐methyl‐
3‐thiosemicarbazide	 (0.5	 g,	 4.75	 mmol)	 in	 ethanol	 (20	 mL).	
The	resulting	brown	solution	was	refluxed	with	stirring	 for	2	
h,	 and	 then	 filtered.	 The	 filtrate	 was	 left	 to	 stand	 at	 room	
temperature	 for	 two	 days,	 and	 block	 colorless	 crystals	 were	
obtained.	M.p:	 198‐200	 °C.	 Yield:	 0.79	 g,	 74%.	 FT‐IR	 (KBr,	 ν,	
cm−1):	 3351,	 3285	 (s,	 NH),	 1601	 (m,	 C=N),	 1548	 (s,	 CaroO),	
1273	(m,	C=S).	1H	NMR	(500	MHz,	DMSO‐d6,	δ,	ppm):	3.01	(s,	
3H,	CH3),	6.27‐8.25	 (m,	3H,	Ar‐H),	8.30	 (q,	1H,	CS‐NH),	11.41	
(s,	1H,	N‐NH).	13C	NMR	(125	MHz,	DMSO‐d6,	ppm):	30.05	(CH3),	
102.28‐160.57	(C‐Ar),	160.34	(C=N),	177.31	(C=S).	Anal.	calcd.	
for	C9H11N3O2S:	C,	 47.99;	H,	4.92;	N,	18.65.	Found:	C,	48.0;	H,	
4.85;	N,	18.68%.		
	
2.4.3.	Synthesis	of	(E)‐2‐(3‐ethoxy‐2‐hydroxybenzylidene)‐
N‐methylhydrazinecarbothioamide	(3)	
	
A	 solution	 of	 3‐ethoxy‐2‐hydroxybenzaldehyde	 (0.78	 g,	
4.75	mmol)	 in	ethanol	(20	mL)	was	added	to	a	solution	of	4‐
methyl‐3‐thiosemicarbazide	(0.5	g,	4.75	mmol)	in	ethanol	(20	
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mL).	The	 resulting	yellow	solution	was	 refluxed	with	stirring	
for	2	h.	A	white	 fluffy	product	was	formed	when	the	solution	
cooled	down	to	room	temperature,	then	filtered,	washed	with	
ethanol	and	air	dried.	Plate	colorless	crystals	were	obtained	by	
slow	evaporation	of	a	DMF	solution	at	room	temperature.	M.p:	
197‐199	°C.	Yield:	0.92	g,	77%.	FT‐IR	(KBr,	ν,	cm−1):	3411	(m,	
NH),	 3176	 (m,	 OH),	 1598	 (s,	 C=N),	 1544	 (s,	 CaroO),	 1268	 (m,	
C=S).	 1H	NMR	(500	MHz,	DMSO‐d6,	δ,	ppm):	1.33	(t,	3H,	CH3),	
3.01	 (s,	 3H,	 CH3),	 4.04	 (q,	 2H,	 CH2),	 6.75‐7.49	 (m,	 3H,	 Ar‐H),	
8.41	 (s,	 1H,	CH=N),	9.13	 (s,	1H,	OH),	11.38	 (s,	1H,	N‐NH).	 13C	
NMR	 (125	 MHz,	 DMSO‐d6,	 ppm):	 14.50	 (Ethoxy‐CH3)	 30.60	
(CH3),	 64.14	 (Ethoxy‐CH2),	 113.91‐146.04	 (C‐Ar),	 146.94	
(C=N),	177.39	(C=S).	Anal.	calcd.	 for	C11H15N3O2S:	C,	52.15;	H,	
5.97;	N,	16.59.	Found:	C,	52.08;	H,	5.89;	N,	16.59%.	
	
2.4.4.	Synthesis	of	(E)‐2‐(3‐(tert‐butyl)‐2‐hydroxy	
benzylidene)‐N‐methylhydrazinecarbothioamide	(4)		
	
A	 solution	 of	 3‐ter‐butyl‐2‐hydroxybenzaldehyde	 (0.84	 g,	
4.75	mmol)	 in	ethanol	(20	mL)	was	added	to	a	 solution	of	4‐
methyl‐3‐thiosemicarbazide	(0.5	g,	4.75	mmol)	in	ethanol	(20	
mL).	 The	 resulting	 colorless	 solution	 was	 refluxed	 with	
stirring	for	2	h	and	then	filtered.	The	filtrate	was	left	to	stand	
at	 room	 temperature;	 a	 white	 product	 was	 then	 collected.	
Block	colorless	crystals	were	obtained	by	slow	evaporation	of	
a	DMF	solution	at	 room	temperature.	M.p:	177‐179	 °C.	Yield:	
0.95	g,	76%.	FT‐IR	(KBr,	ν,	cm−1):	3428	(m,	NH),	3150	(m,	OH),	
1599	 (s,	 C=N),	 1553	 (s,	 CaroO),	 1266	 (s,	 C=S).	 1H	 NMR	 (500	
MHz,	DMSO‐d6,	δ,	ppm):	1.40	(s,	9H,	(CH3)3),	3.01	(s,	3H,	CH3),	
6.87,	 7.28	 (m,	 3H,	 Ar‐H),	 8.29	 (q,	 1H,	 CS‐NH),	 8.51	 (s,	 1H,	
CH=N),	10.02	 (s,	1H,	OH),	11.28	(s,	1H,	N‐NH).	 13C	NMR	 (125	
MHz,	 DMSO‐d6,	 ppm):	 29.35	 ((CH3)3),	 31.16	 (C(CH3)3),	 34.45	
(CH3),	118.65‐146.64	(C‐Ar),	155.19	(C=N),	177.36	(C=S).	Anal.	
calcd.	 for	 C13H19N3OS:	 C,	 58.84;	 H,	 7.22;	 N,	 15.83.	 Found:	 C,	
58.71;	H,	7.16;	N,	15.84	%.		
	
2.4.5.	Synthesis	of	(E)‐N‐methyl‐2‐(1‐(pyridin‐2‐
yl)ethylidene)hydrazinecarbothioamide	(5)	
	
A	 solution	 of	 2‐acetyl	 pyridine	 (0.57	 g,	 4.75	 mmol)	 in	
methanol	 (20	 mL)	 was	 added	 to	 a	 solution	 of	 4‐methyl‐3‐
thiosemicarbazide	 (0.5	 g,	 4.75	 mmol)	 in	 methanol	 (20	 mL).	
The	 resulting	 solution	 was	 refluxed	 with	 stirring	 for	 2	 h.	 A	
white	product	was	formed	when	the	solution	cooled	down	to	
room	temperature,	then	filtered,	washed	with	ethanol	and	air	
dried.	 Block	 colorless	 crystals	 were	 obtained	 by	 slow	
evaporation	of	a	DMF	solution	at	room	temperature.	M.p:	187‐
189	°C.	Yield:	0.80	g,	81%.	FT‐IR	(KBr,	ν,	cm−1):	3301	(m,	NH),	
3146	(m,	OH),	1601	(m,	C=N),	1557	(s,	Caro‐O),	1269	(m,	C=S).	
1H	NMR	(500	MHz,	DMSO‐d6,	δ,	ppm):	2.35	(s,	3H,	CH3),	3.01	(s,	
3H,	CH3),	7.38,	7.83,	8.39,	8.55	(m,	4H,	Ar‐H),	8.65	(q,	1H,	CS‐
NH),	10.28	(s,	1H,	N‐NH).	13C	NMR	(125	MHz,	DMSO‐d6,	ppm):	
12.06	 (CH3),	 31.10	 (N‐CH3),	 120.76‐148.43	 (C‐Ar),	 154.52	
(C=N),	 178.50	 (C=S).	 Anal.	 calcd.	 for	 C9H12N4S:	 C,	 51.90;	 H,	
5.81;	N,	26.90.	Found:	C,	51.21;	H,	5.72;	N,	26.81%.		
	
3.	Results	and	discussion	
	
3.1.	Chemistry	
	
New	 thiosemicarbazones	 (1‐5)	 have	 been	 prepared	
through	 the	 condensation	 of	 corresponding	 salicylaldehyde	
derivatives	 or	 2‐acetylpyridine	 and	 N(4)‐methylthiosemi‐
carbazide	 [32].	 All	 the	 compounds	 are	 air‐stable	 and	 highly	
soluble	 in	 DMSO	 and	 DMF.	 Moreover,	 the	 compounds	 are	
insoluble	 and	 highly	 stability	 in	 aqueous	 solutions.	 1H	 NMR	
and	 UV	 spectra	 were	 recorded	 after	 preparation,	 7	 days,	 15	
days,	 30	 days,	 3	 months	 and	 6	 months,	 while	 kept	 at	 room	
temperature.	 All	 spectra	 confirmed	 the	 stability	 of	 the	
prepared	 compounds	 in	 aqueous	 solutions.	 Compounds	
identity	was	determined	by	 1H	NMR,	 13C	NMR	and	 elemental	
analysis	 which	 are	 confirmed	 their	 assigned	 structures.	 The	
compounds	1‐5	exhibited	well‐resolved	single	crystals,	FT‐IR,	
1H	NMR,	and	13C	NMR	spectra	and	elemental	analysis	charac‐
teristics	consistent	with	their	assigned	structures.		
In	FT‐IR,	the	bands	in	the	1598	to	1610	cm−1	range	can	be	
attributed	to	the	(C=N)	group,	the	bands	 in	the	1544	to	1553	
cm−1	 range	 can	 be	 attributed	 to	 the	 (Caro‐O)	 group,	 and	 the	
bands	in	the	1267	to	1273	cm−1	range	can	be	attributed	to	the	
C=S	group.		
In	 the	 1H	 NMR,	 the	 signal	 caused	 by	 the	 protons	 of	 the	
terminal	 (CH3)	 group	 is	 emerged	 at	 δ	 3.01	 ppm.	 The	 signal	
caused	by	the	proton	of	CS‐NH	group	is	emerged	at	the	range	
from	 δ	 8.28	 to	 8.37	ppm.	 The	 aromatic	 protons	 signals	 are	
observed	 from	δ	6.27	 to	8.25	ppm.	The	signal	 from	δ	8.41	 to	
9.13	ppm	is	attributed	to	the	proton	of	CH=N	group,	whereas	
the	 signals	 from	 δ	 11.38	 to	 11.77	 ppm	 is	 attributed	 to	 the	
proton	of	N‐NH	group.		
In	 the	13C	NMR,	 the	signals	 from	δ	177.31	 to	179.16	ppm	
are	attributed	to	the	carbon	of	C=S	group.	The	carbon	signal	of	
C=N	group	is	appeared	from	δ	146.94	to	160.34	ppm,	and	the	
signals	 of	 aromatic	 carbons	 are	 appeared	 from	 δ	 111.04	 to	
144.58	ppm.	
	
3.2.	Crystal	and	molecular	structures	
	
Crystal	 and	 molecular	 structures	 of	 the	 compounds	 1‐5	
were	 obtained	 using	 crystal	 X‐ray	 diffraction.	 The	 general	
crystal	data	are	 listed	 in	Table	1,	 the	relevant	bond	distances	
and	 angles	 are	 shown	 in	 Table	 2,	 and	 their	 molecular	
structures	are	shown	in	Figures	1‐5.	
The	 compound	 2	 is	 a	 second	 monoclinic	 (P21/c)	
polymorph	 of	 the	 previously	 reported	 Cc	 form	 [33].	 The	
molecule	is	non‐planar,	with	dihedral	angle	between	the	N3CS	
residue	 and	 the	 benzene	 ring	 being	 21.35(4)	 °.	 The	 confor‐
mation	about	the	C=N	bond	(1.291(2)	Å)	is	E,	the	two	N‐bound	
H	 atoms	 are	anti,	 and	 the	 inner	hydroxyl	O‐bound	 and	outer	
amide	N‐bound	H	atoms	form	intramolecular	hydrogen	bonds	
to	 the	 imine	 N	 atom.	 Crucially,	 the	 H	 atom	 of	 the	 outer	
hydroxyl	 group	 is	 approximately	 syn	 to	 the	 H	 atom	 of	 the	
benzene	 C	 atom	 connecting	 the	 two	 C	 atoms	 bearing	 the	
hydroxyl	 substituents.	 This	 arrangement	 enables	 the	 forma‐
tion	of	supramolecular	tubes	aligned	along	[010]	and	sustain‐
ned	by	N‐H∙∙∙O,	O‐H∙∙∙S	and	N‐H∙∙∙S	hydrogen	bonds;	the	tubes	
pack	 with	 no	 specific	 interactions	 between	 them.	 While	 the	
molecular	 structure	 in	Cc	 form	 is	 comparable,	 the	H	 atom	of	
the	 outer	 hydroxyl	 group	 is	 approximately	 anti	 rather	 than	
syn.	This	different	orientation	 leads	 to	 the	 formation	a	 three‐
dimensional	 architecture	 based	 on	 N‐H∙∙∙O	 and	 O‐H∙∙∙S	
hydrogen	bonds	[34].	
The	 molecular	 structures	 of	 compounds	 1‐5	 showed	
different	configurations	according	 their	structural	geometries	
and	elements	symmetry.	 In	 the	compound	1,	2	and	4,	 the	N1	
atom	show	the	trans	geometry	in	relation	to	C5	atom,	and	cis	
geometry	 in	 relation	 to	C1	atom.	These	geometries	 allow	 the	
formation	of	intrahydrogen	bonding	between	N1	atom	and	O1	
atom.	 In	 the	 compound	3,	 the	 aromatic	 ring	 rotates	 approxi‐
mately	180	°	around	the	N1‐C7	bond	which	leads	to	change	the	
trans	geometry	to	cis	geometry	between	N1	atom	and	C5	atom	
(corresponded	 to	C1	 in	compound	1,	2	 and	4),	as	well	as	 the	
cis	geometry	to	trans	geometry	between	N1	atom	and	C1	atom	
(corresponded	 to	 C5	 atom	 in	 compound	 1,	 2	 and	 4).	 These	
geometries	 prevent	 the	 formation	 of	 intrahydrogen	 bonding	
between	N1	 and	O1.	 Furthermore,	 the	 compounds	1‐4	 show	
the	trans	geometries	between	N1	atom	and	S1	atom	as	well	as	
between	C9	atom	and	N2	atom,	and	cis	geometries	between	N1	
atom	and	N2	atom	as	well	as	between	C9	atom	and	S1	atom.	
The	 compound	4	was	 reported	 in	 our	previous	work	but	
has	not	been	isolated	as	a	single	crystal	[35].	The	asymmetric	
unit	of	the	compound	4	contains	three,	A,	B	and	C,	C13H19N3OS	
and	three	C3H7NO	solvent	molecules.	Such	crystallographically	
different	units	have	been	rarely	isolated	[36].		
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Table	1.	Crystallographic	data	of	compounds	1‐5.		
Parameter		 1	 2	 3	 4	 5	
Chemical	formula		 C9H10BrN3OS	 C9H11N3O2S C11H15N3O2S C13H19N3OS,	C3H7NO	 C9H12N4S	
Formula	weight	 288.17	 225.28 253.33 338.48 208.30	
Crystal	system	 Monoclinic	 Monoclinic	 Monoclinic	 Triclinic	 Monoclinic	
Crystal	description	 Plate	yellow	 Block	colorless	 Plate	colorless	 Block	colorless	 Block	colorless	
Space	group	 P21/c	 P21/c	 P21/c	 P‐1	 P21/c	
a	(Å)	 8.3776(1)	 7.3058(2)	 14.3413(7)	 12.4996(2)	 8.7849(3)	
b	(Å)	 6.2010(1)	 6.0582(1) 6.0078(3) 13.4853(2) 7.5662(3)
c	(Å)	 21.1050(3)	 22.6041(6) 16.2414(7) 17.1744(2) 15.4579(5)	
α	(°)	 90	 90 90 99.975(1) 90	
β	(°)	 94.552(1)	 91.100(2) 117.557(3) 93.220(1) 105.734(2)
γ	(°)	 90	 90 90 106.833(1) 90	
Volume	(Å3)	 1092.94(3)	 1000.27(4) 1240.60(11) 2711.59(7) 988.96(6)
Z	 4	 4 4 6 4	
Dcalc	(g/cm3)	 1.822	 1.496	 1.356	 1.244	 1.399	
Crystal	size	(mm)	 0.07	×	0.29	×	0.45	 0.41	×	0.19	×	0.48	 0.08	×	0.16	×	0.65	 0.15	×	0.24	×	0.46	 0.22	×	0.33	×	0.40	
Temperature	(K)	 100	 100 100 100 100	
Total	data	 22785	 11216	 12899	 58926	 13353	
Unique	data	 4831	 2939 3287 15795 3598	
Rint	 0.030	 0.029 0.049 0.066 0.029	
Observed	data	[I>2σ(I)]	 3856	 2389 2224 9130 3052	
R1	 0.0307	 0.0391 0.0474 0.0694 0.0372	
wR2	 0.0694	 0.0974 0.1058 0.1423 0.0901	
s	 1.07 1.05 1.04 1.03 1.06	
	
	
Table	2.	Selected	bond	length	(Å)	and	angles	(°)	for	the	compounds	1‐5.	
Compound	 1	 2	 3	 4A	 4B	 4C	 5	
Bond	distances	(Å)	 	 	 	
N2‐C8	 1.3585(19)	 1.3627(19)	 1.359(3) 1.355(3) 1.354(3) 1.356(3)	 1.3684(14)*
S1‐C8	 1.6885(14)	 1.7001(13)	 1.693(2)	 1.700(2)	 1.695(2)	 1.698(2)	 1.6897(11)*	
N1‐N2	 1.3801(18)	 1.3934(17)	 1.376(2)	 1.383(3)	 1.384(3)	 1.380(3)	 1.3752(14)*	
N3‐C8	 1.3287(18)	 1.3234(18)	 1.326(3)	 1.322(3)	 1.323(3)	 1.356(3)	 1.3296(14)*	
N3‐C9	 1.455(2)	 1.459(2)	 1.451(3)	 1.454(3)	 1.453(3)	 1.448(3)	 1.4572(14)*	
N1‐C7	 1.2880(19)	 1.2927(18)	 1.284(3) 1.287(3) 1.283(3) 1.288(3)	 1.2927(14)*
Bond	angels	(°)	 	 	 	
N1‐N2‐C8	 121.89(12)	 120.32(11)	 120.43(17)	 122.17(18)	 121.67(18)	 121.78(18)	 118.48(9)	
S1‐C8‐N3	 75.47(11)	 118.02(12)	 124.49(18)	 123.16(18)	 123.51(17)	 123.30(18)	 123.61(8)	
S1‐C8‐N2	 118.04(10)	 117.98(10)	 119.50(15)	 118.55(16)	 118.70(16)	 118.56(15)	 119.63(8)	
C8‐N3‐C9	 123.35(13)	 124.57(13)	 124.29(19)	 122.6(2)	 123.0(2)	 123.2(2)	 123.29(10)	
N2‐N1‐C7	 114.26(12)	 113.65(11)	 115.28(16) 114.55(17) 114.89(17) 114.93(17)	 117.77(9)
*	For	5;	N1=N2,	N2=N3,	N3=N4,	C8=C7	and	C7=C6.		
	
	
	
	
Figure	1.	Molecular	structure	of	compound	1.	
	
	
	
	
Figure	2.	Molecular	structure	of	compound	2.	
	
The	 molecular	 structures	 show	 the	 4A	 and	 4B	 have	 the	
same	conformations	and	the	4C	is	enantiomer.	Therefore,	the	
4A	 and	4B	 show	 the	 anti‐conformation	 of	 the	 N1	 atom	with	
respect	 to	 S1	 atom	 (Torsion	 angle	 N1A–N2A–C8A–S1A	 =													
‐176.37(15)	°	and	torsion	angle	N1B–N2B–C8B–S1B	=	‐172.53	
(15)	°),	O1	atom	with	respect	to	C3	atom	(Torsion	angle	O1A–
C1A–C2A–C3A	 =	 ‐179.23(18)	 °	 and	 torsion	 angle	 O1B–C1B–
C2B–C3B	 =	 ‐179.24	 (18)	 °),	 whereas	 4C	 shows	 the	 syn‐
conformations	 (Torsion	 angle	 N1C–N2C–C8C–S1C	 =	 175.89	
(15)	 °	and	torsion	angle	O1C–C1C–C2C–C3C	=	178.76	(19)	°).	
In	 addition,	4A	 and	4B	 show	 the	 syn‐conformation	 of	 the	 C9	
atom	with	respect	 to	S1	atom	(Torsion	angle	C9A–N3A–C8A–
S1A	=	2.3(3)	°	and	torsion	angle	C9B–N3B–C8B–S1B	=	4.0(3)°),	
C1	 atom	with	 respect	 to	C11	 atom	 (Torsion	 angle	 C1A–C2A–
C10A–C11A	=	177.41(9)	 °	and	 torsion	angle	C1B–C2B–C10B–
C11B	=	178.6(2)	°),	whereas	4C	shows	the	anti‐conformations	
(Torsion	angle	C9C–N3C–C8C–S1C	=	‐3.8(3)°	and	torsion	angle	
C1C–C2C–C10C–C11C	 =	 ‐177.7(2)°).	 In	 the	 compound	 5,	 the	
N2	 atom	 shows	 the	 trans	 geometries	 in	 relation	 to	 N1	 atom	
and	 S1	 atom,	 as	 well	 as	 the	 N3	 atom	 shows	 the	 trans	
geometries	 in	 relation	 to	 C5	 atom	 and	 terminal	 C8	 atom.	
Furthermore,	the	cis	geometries	appear	between	S1	atom	and	
C8	 atom	 as	well	 as	 between	N1	 atom	 and	 C9	 atom	which	 is	
occupy	 the	 apical	 position.	 Moreover,	 the	 N2‐C8	 and	 C8‐S1	
bond	distances	indicate	the	thione	form	for	all	the	compounds,	
which	has	been	changed	to	thiol	form	upon	complexation	[37].	
	
	
	
Figure	3.Molecular	structure	of	compound	3.	
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Table	3.	Selected	hydrogen	bonds	parameters	of	the	compounds	1‐5	(Å	and	°).	
Compound	 D‐H∙∙∙A	 Symmetry	 d(D‐H)	 d(H∙∙∙A)	 d(D∙∙∙A)	 ˂(DHA)	
1	 N3‐H∙∙∙N1	 	 0.77(2) 2.40(2) 2.7242(18)	 106.8(18)
	 N2‐H∙∙∙O1	 x,	‐1+y,	z	 0.81(2) 2.29(3) 3.0579(17)	 3.0579(17)
	 O1‐H∙∙∙N1	 	 0.76(3) 2.02(3) 2.6809(17)	 146(3)
2	 N2‐H∙∙∙O1	 x,	1+y,	z	 0.90(2) 2.08(2) 2.9531(17)	 162(2)
	 N3‐H∙∙∙S1	 x,	‐1+y,	z	 0.822(19) 2.758(18) 3.3877(13)	 134.8(17)
	 N3‐H∙∙∙N1	 	 0.822(19) 2.35(2) 2.7074(18)	 106.8(16)
3	 N2‐H∙∙∙O2	 1‐x,	2‐y,	2‐z	 0.85(2)	 2.16(2)	 2.955(2)	 155(2)	
	 N3‐H∙∙∙N1	 	 0.83(2)	 2.23(3)	 2.639(3)	 111(2)	
	 O2‐H∙∙∙O1	 	 0.82(3) 2.16(2) 2.619(2)	 115(2)
	 O2‐H∙∙∙S1	 1‐x,	2‐y,	2‐z	 0.82(3) 2.52(3) 3.2107(17)	 142(2)
4	 N2A‐H∙∙∙S1B	 2‐x,	1‐y,	‐z	 0.84(3) 2.55(3) 3.3670(19)	 166(2)
	 N2B‐H∙∙∙S1A	 2‐x,	1‐y,	‐z	 0.84(2)	 2.58(2)	 3.3989(19)	 166(2)	
	 N3B‐H∙∙∙O2B	 1+x,	y,	z	 0.87(2)	 2.18(2)	 2.918(3)	 143(2)	
	 N2C‐H∙∙∙S1C	 x,	1+y,	z	 0.89(3)	 2.50(3)	 3.3675(19)	 165(2)	
5	 N4‐H∙∙∙N2	 	 0.857(17) 2.242(17) 2.6302(14)	 107.5(13)
	 N4‐H∙∙∙S1	 2‐x,	‐1/2+y,	1/2‐z	 0.857(17)	 2.769(16)	 3.4594(10)	 138.7(14)	
	 N3‐H∙∙∙S1	 2‐x,	2‐y,	‐z	 0.865(16) 2.715(16) 3.5487(10)	 162.5(13)
	
	
	
	
Figure	4.	Molecular	structure	of	compound	4.	Molecular	structures	of	A,	B	
and	C.	
	
	
	
	
Figure	5.	Molecular	structure	of	compound	5.	
	
From	 the	 other	 hand,	 the	 crystal	 structure	 of	 the	
compound	 1‐5	 form	 centrosymmetrically	 related	 dimmers	
through	the	intermolecular	hydrogen	bonds;	their	parameters	
are	listed	in	Table	3.	
	
3.3	Interaction	with	DNA	
	
3.3.1.	Electronic	absorption	studies		
	
Electronic	absorption	is	one	of	the	most	useful	methods	in	
DNA	binding	studies	[38,39].	Compounds	bind	to	DNA	through	
covalent	 bonding	 [40]	 or	 noncovalent	 interaction,	 such	 as	
intercalation,	 electrostatic	 binding,	 or	 groove	 binding	 [41].	
Absorption	 spectroscopic	 studies	 were	 carried	 out	 on	 a	
spectrophotometer	 (Perkin	 Elmer,	 Lambda‐35),	 using	 fixed	
concentrations	of	the	ligand	(50	µM)	with	increasing	amounts	
of	DNA	from	28.9	µM	to	173.4	µM	in	6.3	mM	Tris‐HCl/50	mM	
NaCl	buffer	(pH	=	7).	Each	addition	left	for	equilibrium	at	25	°C	
for	 10	 min.	 and	 scanned	 from	 230	 to	 600	 nm.	 All	 the	
compounds	 revealed	 two	 absorption	 bands	 attributed	 to	 the	
π→π*	and	n→π*	 transitions	at	305	and	338	nm,	respectively.	
The	 π→π*	 absorption	 bands	 were	 used	 to	 observe	 the	
interaction	of	CT‐DNA	with	compounds.	The	observed	spectral	
behavior	suggest	 intercalative	 interaction	 to	DNA	[42],	which	
lead	to	hypochromism	in	spectral	bands	with	 increasing	DNA	
concentration	(Figure	6).	The	change	in	absorbance	was	used	
to	estimate	the	 intrinsic	binding	constant	Kb	at	305	nm	using	
the	following	equation	(1)	[43]:	
	
	[DNA]	/	(	εa	−	εf	)	=	[DNA]	/	(	εb	−	εf	)	+	1/Kb	(	εb	−	εf	)		 (1)	
	
where	 the	 absorption	 coefficients	 εa,	 εf,	 and	 εb	 correspond	 to	
Aabs/[DNA],	 the	 extinction	 coefficient	 for	 the	 free	 compound,	
and	 the	 extinction	 coefficient	 for	 the	 ligand	 in	 fully	 bound	
form,	 respectively.	 The	 plot	 of	 [DNA]/(εa‐	 εf)	 versus	 [DNA]	
gives	a	slope	1/(εa	−	εf)	and	intercept	1/Kb	(εb	−	εf)	as	shown	in	
Figure	7.		
The	 binding	 constants	 (Table	 4)	 suggest	 that	 all	 the	
compounds	 are	 strongly	 bind	 to	 the	 CT‐DNA.	 The	 Kb	 values	
shows	that	the	binding	strength	follow	the	order,	4	>	5	>	1	>	2	
>	3.	 In	addition	of	an	 influence	of	 the	terminal	methyl	group,	
the	presence	of	tert‐butyl	group	provides	a	strong	lipophilic	or	
hydrophobic	 medium	 which	 enables	 the	 compound	 4	 (Kb	 =	
1.834×105	M‐1)	to	move	into	the	hydrophobic	medium	of	DNA	
and	 consequently	 moves	 rapidly	 between	 the	 DNA	 bases	
which	 in	 turn	 bind	 strongly	 with	 DNA	 compared	 to	 the	
compound	5	(Kb	=	1.662×105	M‐1)	that	have	one	methyl	group.	
The	 polarized	 bromine	 moiety	 increases	 the	 London	
dispersion	 forces	 and	 consequently	 increases	 the	 lipophilic	
properties	which	makes	the	compound	1	(Kb	=	8.791×104	M‐1)	
a	 strong	 intercalator.	 Moreover,	 the	 binding	 strength	 is	
depends	on	the	planarity	of	the	compounds	which	provided	by	
the	 geometrical	 and	 conformational	 structures,	 a	 strong	
intercalator	 that	 have	more	 planarity	 [44].	 The	 compound	3	
showed	 different	 geometrical	 structures	 than	 the	 other	
compounds	 as	 mentioned	 the	 crystal	 section,	 and	 may	 be	
responsible	 about	 the	 binding	 strength	 of	 this	 compound	 as	
well	 as	 the	 presence	 of	 the	 withdrawing	 ethoxy	 group	
compared	 to	 donating	 hydroxyl	 group	 which	 is	 makes	 the	
compound	 2	 (Kb	 =	 6.551×104	 M‐1)	 a	 good	 intercalator	 than	
compound	3	(Kb	=	4.873×104	M‐1).	Furthermore,	the	binding	of	
the	compounds	to	CT	DNA	caused	isosbestic	spectral	changes	
with	an	isosbestic	points	at	289	nm.	The	presence	of	isosbestic	
points	 are	 attributed	 to	 the	 increasing	 concentration	 of	DNA	
which	leads	to	increasing	absorbance	in	this	region.	
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Figure	6.	UV	spectra	of	the	compounds	1‐5,	in	6.3	mM	Tris‐HCl/50	mM	NaCl	buffer	(pH	=	7)	in	presence	of	CT‐DNA	at	increasing	amounts.	[Compound]	=	50	
µM,	[DNA]	=	(28.9‐173.4)	µM.	The	arrows	show	the	changes	in	absorbance	upon	increasing	amounts	of	CT‐DNA.	IP	=	Isosbestic	point.	
	
	
3.3.2.	Fluorescence	emission	studies	
	
Emission	 spectral	 studies	 were	 carried	 out	 in	 order	 to	
evaluation	the	changes	that	accompany	the	CT‐DNA	additions	
on	 the	 fluorescence	 spectra	 of	 the	 synthesized	 compounds.	
The	 fluorescence	 emission	 is	 due	 to	 return	 the	molecules	 to	
the	electronic	ground	state	π	from	the	electronic	excited	state	
π*	 rather	 than	 the	 n→π*	 transition	 because	 the	 quantum	
efficiency	is	greater	and	the	lifetime	is	shorter	than	that	for	the	
n→π*	transition	[45].	The	compounds	2,	3	and	5	showed	two	
fluorescence	 emission	 at	 380	 nm	 and	 at	 longer	 wavelength,	
500	nm,	due	to	 isosbestic	spectral	changes	with	an	 isosbestic	
points	 at	 408	 nm,	 presumably	 due	 to	 formation	 of	 excimer	
(Figure	8).	The	 isosbestic	points	are	not	commonly	appear	 in	
fluorescence	spectra,	anyway,	the	presence	of	isosbestic	point	
is	attributed	to	the	rigidity	and	steric	features	that	succeed	to	
bring	the	molecules	close	enough	which	assist	to	generate	an	
excimer	molecule.	
In	 the	 compound	2,	 the	presence	of	 hydroxyl	 substituent	
on	 aromatic	 ring	 decreases	 the	 intensity	 of	 the	 monomeric	
fluorescent	peak	at	380	nm,	which	suggest	that	the	probability	
of	 intersystem	 crossing	 increases	 depending	 on	 the	 molar	
mass	 of	 the	 substituent.	 By	 contrast,	 the	 presence	 of	 ethoxy	
and	methyl	moieties	increases	the	intensity	of	the	monomeric	
fluorescent	peak	at	380	nm	of	compound	3	and	5,	respectively,	
due	 to	 increases	 the	 rigidity	 via	 the	 formation	 of	 hydrogen	
bonding	 [46].	The	compound	1	showed	three	emission	peaks	
at	380	nm	back	 to	 the	monomeric	molecule,	 500	nm	back	 to	
the	 first	 excimer	 molecule	 and	 760	 nm	 back	 to	 the	 second	
excimer	 molecule.	 In	 general,	 the	 fluorescence	 emission	
decreases	 upon	 addition	 of	 CT‐DNA	 which	 confirms	 the	
intercalative	binding	between	the	compounds	and	DNA.	From	
the	 other	 hand,	 the	 CT‐DNA	 addition	 to	 the	 compounds	
decreases	the	intensity	of	the	excimer	fluorescent	peaks	at	500	
nm	and	 increases	 the	 intensity	of	 the	monomeric	 fluorescent	
peaks	at	380	nm.	
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Figure	7.	Plots	of	[DNA]/(εa – εf)	vs [DNA].
	
	
These	 changes	 are	 suggest	 that	 the	 interaction	 occurs	
between	 the	 excimer	molecule	 and	 DNA	 and	 hence	 separate	
the	 monomer	 molecule	 which	 leads	 to	 increases	 the	
fluorescence	intensity	at	380	nm	[47].	The	compound	4	shows	
one	 fluorescence	 emission	 at	 380	 nm,	which	 is	 the	 intensity	
decreases	upon	addition	the	DNA	to	the	ligand.		
	
3.3.3.	Viscosity	measurement	
	
Viscosity	assays	are	regarded	as	one	of	the	most	important	
tests	 for	 assessing	 the	 binding	modes	 of	 compounds	 to	DNA.	
Intercalation	 of	 compounds	 into	 DNA	 increases	 the	 viscosity	
because	of	the	extension	and	stiffening	of	 the	DNA	helix	[48].	
The	viscometric	studies	were	performed	by	adding	increasing	
amounts	of	the	compounds	to	fixed	amount	of	CT	DNA	at	37	°C	
in	6.3	mM	Tris‐HCl/50	mM	NaCl	buffer	 (pH	=	7).	The	corres‐
ponding	results	are	 shown	 in	Figure	9.	These	results	 confirm	
the	 intercalative	 binding	 and	 support	 the	 spectrometric	
results.	
	
3.4.	Antiproliferative	activity	
	
Antiproliferation	tests	were	performed	 in	vitro	on	human	
colorectal	cancer	(HCT	116)	cell	line.	The	compounds	showed	
a	 pronounced	 activity	 than	 the	 standard	 reference,	 5‐
fluorouracil	(median	inhibitory	concentration	[IC50]	=	7.3	µM).	
The	IC50	values	of	the	tested	compounds	(Table	4)	showed	that	
the	order	of	antiproliferative	efficiency	was	4	>	5	>	1	>	2	>	3.		
	
Table	4.	DNA	binding	constants	(Kb)	and	IC50	of	compounds	1‐5.	
Compound Kb	(M‐1) IC50	(µM)
1	 8.791×104	 4.1	
2	 6.551×104	 4.5	
3	 4.873×104	 6.3	
4 1.834×105 3.3	
5 1.662×105 3.5	
5‐FU	 ‐ 7.3	
	
These	results	are	consistent	with	 those	obtained	 for	DNA	
binding	and	confirm	that	the	compound	activity	is	dependent	
on	the	substituent	of	the	aromatic	ring,	a	100	µM	4,	5,	1,	2	and	
3	 is	 sufficient	 to	 inhibit	 97.6,	 95.6,	 85.9,	 70.2	 and	 62.0%	 cell	
proliferation,	 respectively	 (Figure	 10).	 Figure	 11	 shows	 the	
HCT	 116	 cell	 images	 after	 48	h	 of	 treatment	 with	 the	
compounds.	 These	 images	 were	 taken	 with	 inverted	 phase‐
contrast	 microscopy	 at	 ×200	 magnification	 and	 a	 digital	
camera	at	48	h	after	treatment	of	the	samples.	The	analysis	of	
the	 photomicrographs	 shows	 that	 the	 compounds	 generally	
showed	apoptotic	features	in	the	affected	cells.	The	blabbing	of	
the	 cell	membrane	 and	 vesicle	 formation	 in	 the	 treated	 cells	
indicate	the	unique	characteristics	of	apoptosis.	
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Figure	 8.	 Fluorescence	 spectra	 of	 the	 compounds	 1‐5,	 in	 6.3	 mM	 Tris‐HCl/50	 mM	 NaCl	 buffer	 (pH	 =	 7)	 in	 presence	 of	 CT‐DNA	 at	 increasing	 amounts.	
[Compound]	=	50	µM,	[DNA]	=	(28.9‐173.4)	µM.	The	arrows	show	the	changes	in	fluorescence	intensity	upon	increasing	amounts	of	CT‐DNA.	IP	=	Isosbestic	
point.	
	
	
	
	
Figure	9.	Viscometric	 results	 of	 the	 compounds	1‐5,	 in	 6.3	mM	 Tris‐HCl/50	mM	NaCl	 buffer	 (pH	 =	 7)	 in	 presence	 of	 CT‐DNA	 and	 increasing	 amounts	 of	
compound	at	37	°C;	r	=	[Compound]/[DNA].	
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Figure	10.	Cell	proliferation	inhibition	by	the	compounds	1‐5 at	concentration	range	3.0,	6.0,	12,	25,	50	and	100	µM	using	5‐FU	as	a	reference.
	
	
	
Figure	11.	Photomicrographs	of	the	HCT	116	cell	lines	after	treatment	with	the	compounds	and	5‐FU	as	standard	reference.	
	
	
4.	Conclusions	
	
Five	 new	 thiosemicarbazones	 derivatives	 were	 synthe‐
sized,	 characterized	 and	 structurally	 identified	 using	 X‐ray	
crystallographic	 technique.	 Compound	 4	 revealed	 rarely	
observed	crystallographically	different	three	units	of	the	same	
molecule	 which	 have	 slightly	 different	 bond	 lengths	 and	
angles.	 Such	 crystallographically	 different	 units	 have	 been	
rarely	 isolated.	 The	 binding	 strength	 of	 compounds	with	 CT‐
DNA	 as	well	 as	 their	 antiproliferative	 activity	 against	 human	
colorectal	cancer	(HCT	116)	cell	 line	has	been	evaluated.	The	
results	 showed	 the	 intercalation	 interaction	 between	 the	
compounds	and	DNA.	The	compounds	4	 and	5	 showed	more	
pronounced	 binding	 strength	 as	 well	 as	 cytotoxic	 properties	
and	found	to	have	considerable	antiproliferative	abilities	than	
compared	to	compound	1,	2	and	3.	The	current	study	revealed	
that	 the	 terminal	 N(4)‐methyl	 group	 and	 the	 substituent	
methyl	 groups	 on	 aromatic	 ring	 are	 more	 increased	 the	
binding	 strength	 compared	 to	 bromine	 group.	 Furthermore,	
the	presence	of	donating	group	on	aromatic	ring	increases	the	
strength	 of	 intercalator	 compared	 to	 the	 presence	 of	
withdrawing	 group.	 Moreover,	 the	 study	 revealed	 that	 the	
binding	 strength	 depends	 on	 the	 planarity	 that	 provided	 by	
the	geometrical	and	conformational	structures	of	compound.		
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